Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$170.78 - $208.42 $26.8 Million - $32.7 Million
156,958 New
156,958 $28.9 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $4.45 Million - $7.1 Million
27,714 Added 67.57%
68,732 $12.9 Million
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $2.13 Million - $2.85 Million
-15,138 Reduced 26.96%
41,018 $6.66 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $8.18 Million - $13.1 Million
-50,770 Reduced 47.48%
56,156 $10.6 Million
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $4.56 Million - $5.6 Million
18,400 Added 20.78%
106,926 $28.3 Million
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $7.2 Million - $12 Million
36,985 Added 71.76%
88,526 $25.6 Million
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $923,066 - $1.23 Million
5,565 Added 12.1%
51,541 $10.3 Million
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $129,866 - $162,907
-720 Reduced 1.54%
45,976 $8.94 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $1.61 Million - $2.25 Million
10,887 Added 30.4%
46,696 $8.95 Million
Q3 2020

Nov 16, 2020

SELL
$122.51 - $158.27 $86,737 - $112,055
-708 Reduced 1.94%
35,809 $5.28 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $3.31 Million - $4.93 Million
-35,069 Reduced 48.99%
36,517 $4.51 Million
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $645,611 - $829,354
-7,599 Reduced 9.6%
71,586 $6.91 Million
Q4 2019

Feb 12, 2020

BUY
$73.84 - $93.08 $1.82 Million - $2.29 Million
24,599 Added 45.06%
79,185 $7.33 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $1.12 Million - $1.39 Million
14,560 Added 36.38%
54,586 $4.19 Million
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $460,645 - $730,489
8,499 Added 26.96%
40,026 $3.44 Million
Q1 2019

May 15, 2019

BUY
$49.45 - $62.8 $8,455 - $10,738
171 Added 0.55%
31,527 $1.86 Million
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $1.51 Million - $2.16 Million
31,356 New
31,356 $1.65 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.66B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Driehaus Capital Management LLC Portfolio

Follow Driehaus Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.